Company Overview

Company name: Lexaria Bioscience (PINX: LXRP)
Description: Lexaria Bioscience Corp is a food science company. The company’s food sciences activities include the development of the proprietary nutrient infusion technologies for the production of superfoods, and the production of enhanced food products under two consumer product brands, ViPova and Lexaria Energy. The company’s patented lipid nutrient infusion technology DehydraTECHTM is believed to improve taste, rapidity, and delivery of bioactive compounds that include cannabinoids, vitamins NSAIDs Nicotine and other molecules.
Year founded: 2004
Parent company:
Industry: Healthcare | Group: | Code:
Employees: 3
City: Kelowna
State: British Columbia
Country: Canada

Financial Highlights

Start up capital raised (USD Million): 2.04
Business status: Generating Revenue/Not Profitable
Ownership: Publicly Held
Exchange: PINX
Ticker: LXRP
Revenue (USD Million): 0.35
Gross profit (USD Million): 0.27
Net income (USD Million) -4.11
Enterprise value: 25.45
Earnings before interest, tax, depreciation and amortization (EBITDA): -4.12
Fiscal period: TTM 2Q2020
Financing Status: The company (PINX:LXRP) received $2.039 million of development capital from undisclosed investors on May 11, 2020 through a private placement. The Company intends to use the proceeds from the Offering to perform and complete its recently announced human pilot study researching effectiveness of DehydraTECH technology related to enhancing the oral bioavailability of certain antiviral drugs of potential use against COVID-19 or other infectious disease states, to fund the application process for a senior US exchange listing application and for general working capital.
Number of active investors:
Profile last updated: 28-May-2020
Last known valuation:
Last known valuation date: